...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Evaluation of Antidiabetic Activity of the Leaf Latex of Aloe pulcherrima Gilbert and Sebsebe (Aloaceae)
【24h】

Evaluation of Antidiabetic Activity of the Leaf Latex of Aloe pulcherrima Gilbert and Sebsebe (Aloaceae)

机译:芦荟胶胶叶乳糖和Sebsebe(Aloaceae)的抗糖尿病的评价

获取原文
           

摘要

The leaf latex of Aloe pulcherrima has been used as remedy for diabetes mellitus. This was carried out to determine in vitro and in vivo antidiabetic activities of the leaf latex of Aloe pulcherrima. Methods. Sucrase and maltase inhibitory activity of the leaf latex of A. pulcherrima was determined in glucose oxidase assay, and α-amylase inhibitory activity was determined in dinitrosalicylic acid assay. Normoglycemic, glucose-loaded, and streptozotocin-induced diabetic mice were treated orally to determine blood glucose lowering activity of the latex. Effect of the latex on serum lipid level and body weight was measured in streptozotocin-induced diabetic mice. Additionally, DPPH assay was used to determine free radical scavenging capacity of the latex. Results. Antioxidant activity of the latex was concentration dependent; the strongest inhibition was measured at 800?μg/ml (80.57%). The leaf latex of A. pulcherrima inhibited sucrase (IC50?=?2.92?μg/ml), maltase (IC50?=?11.81?μg/ml) and α-amylase (IC50?=?14.92?μg/ml) enzymes. All doses of the leaf latex induced hypoglycemic effect after 4?h in normal mice, and low dose of the latex did not show significant effect after 6?h. Glucose reduction of the leaf latex of A. pulcherrima was significant (p0.05) in oral glucose-loaded mice compared to the vehicle control. Blood glucose level of diabetic mice was significantly (p0.05) reduced on week one and weak two in a streptozotocin-induced diabetic mouse model. Glucose reduction increased with increasing the doses of the leaf latex of A. pulcherrima on week one (p0.05 (200?mg/kg), p0.01 (400?mg/kg), and p0.001 (600?mg/kg)). Administration of the leaf latex of A. pulcherrima for two weeks significantly (p0.05) improved diabetic dyslipidemia and body weight of diabetic mice. Conclusion. The study confirmed that the leaf latex of the plant showed a significant antidiabetic activity justifying the traditional uses of the plant.
机译:芦荟普拉氏菌的叶子乳胶被用作糖尿病糖尿病的补救措施。这是为了确定芦荟脉冲叶乳胶的体外和体内抗糖尿病活性。方法。在葡萄糖氧化酶测定中测定了A.Pulcherrima的叶片胶乳的蔗糖酶和畸形抑制活性,并在二硝基水杨酸测定中测定α-淀粉酶抑制活性。口服对常规血糖,葡萄糖诱导的糖尿病小鼠进行治疗,以确定胶乳的血糖降低活性。在链脲佐菌素诱导的糖尿病小鼠中测量乳胶对血清脂质水平和体重的影响。另外,DPPH测定用于确定乳胶的自由基清除能力。结果。胶乳的抗氧化活性浓度依赖性;在800×μg/ ml(80.57%)下测量最强的抑制。 A.Pulcherrima的叶片胶乳抑制了苏克基酶(IC50?=α.2.92?μg/ ml),麦芽酶(IC50?= 11.81×11.81Ω·μg/ mL)和α-淀粉酶(IC50?= 14.92×14.92×14.92×14.92×14.92×14.92×14.92×14.92×14.92℃)酶。所有剂量的叶乳蛋白在正常小鼠中4μlh的叶血糖效果诱导低血糖效果,低剂量的乳胶在6μm后没有显示出显着效果。与载体控制相比,A.Pulcherrima的叶片胶乳的叶片胶乳的葡萄糖还原在口腔葡萄糖加载的小鼠中显着(p <0.05)。在链脲佐菌素诱导的糖尿病小鼠模型中,每周1和弱两组减少糖尿病小鼠的血糖水平(P <0.05)。随着A. pulcherrima的叶片胶乳的剂量在一周内增加葡萄糖减少(P <0.05(200?mg / kg),p <0.01(400×mg / kg)和p <0.001(600?mg /公斤))。施用A. pulcherrima的叶片胶乳两周(P <0.05)改善糖尿病血脂血症和糖尿病小鼠体重。结论。该研究证实,该植物的叶片乳胶显示出了重要的抗糖尿病活动,证明了植物的传统用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号